Effects of Dexmedetomidine on Perioperative Glycemic Control in Adult Diabetic Patients Undergoing Cardiac Surgery
Annals of Cardiac Anaesthesia · 2024
DOI: 10.4103/aca.aca_209_23 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of Cardiac Anaesthesia, 2024. Verfasst von Nagarjuna Panidapu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Anesthesia, Amrita Institute of Medical Sciences, Kochi, Kerala, India. Hauptthemen laut MEDLINE: Dexmedetomidine, Cardiac Surgical Procedures, Blood Glucose, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and Objective: To study the effects of dexmedetomidine (DEX) on perioperative blood glucose levels in adult diabetes mellitus (DM) patients undergoing cardiac surgery. Methods and Material: A prospective, observational study was conducted on 100 adult diabetic patients aged between 18 and 75 years undergoing cardiac surgery with cardiopulmonary bypass (CPB). The patients were divided into two groups (group D and group C) of 50 each. Group D patients received DEX infusion, whereas the group C patients received 0.9% normal saline infusion.
Results
The blood glucose levels, heart rate, mean arterial pressure, and serum potassium levels at different time points were comparable between the two groups ( P > 0.05). The mean dose of insulin required in the combined population as well as in both controlled and uncontrolled DM patients was significantly less in group D than in group C (combined population - 36.03 ± 22.71 vs 47.82 ± 30.19 IU, P = 0.0297; uncontrolled DM - 37.36 ± 23.9 IU vs 48.16 ± 25.15 IU, P = 0.0301; controlled DM - 34.7 ± 21.5 IU vs 47.63 ± 35.25 IU, P = 0.0291). Duration of mechanical ventilation and VIS were comparable between the two groups. The incidence of arrhythmias (20% vs 46%, P = 0.0059) and delirium (6% vs 20%, P = 0.0384) was significantly less in group D than in group C. None of the patients in either group had stroke, myocardial ischemia, and mortality.
Conclusion
The results suggested that DEX infusion during the intraoperative period was very effective for perioperative glycemic control and reduction of insulin requirement in DM patients undergoing cardiac surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Anesthesia, Amrita Institute of Medical Sciences, Kochi, Kerala, India.
- Division of Cardiothoracic and Vascular Anesthesia, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
Zitieren
APA
Panidapu, N., Babu, S., Gadhinglajkar, S. V., Thomas, D., Aspari, A. M., & Sen, B. (2024). Effects of Dexmedetomidine on Perioperative Glycemic Control in Adult Diabetic Patients Undergoing Cardiac Surgery. Annals of Cardiac Anaesthesia. https://doi.org/10.4103/aca.aca_209_23
Vancouver
Panidapu N, Babu S, Gadhinglajkar SV, Thomas D, Aspari AM, Sen B. Effects of Dexmedetomidine on Perioperative Glycemic Control in Adult Diabetic Patients Undergoing Cardiac Surgery. Annals of Cardiac Anaesthesia. 2024. doi:10.4103/aca.aca_209_23
BibTeX
@article{Panidapu2024,
author = {Panidapu, Nagarjuna and Babu, Saravana and Gadhinglajkar, Shrinivas V and Thomas, Diana and Aspari, Azeez Mahammad and Sen, Barsha},
title = {Effects of Dexmedetomidine on Perioperative Glycemic Control in Adult Diabetic Patients Undergoing Cardiac Surgery},
journal = {Annals of Cardiac Anaesthesia},
year = {2024},
doi = {10.4103/aca.aca_209_23}
}
EUVIMED